Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

✍ Scribed by Kwaku Poku Asante; Salim Abdulla; Selidji Agnandji; John Lyimo; Johan Vekemans; Solange Soulanoudjingar; Ruth Owusu; Mwanajaa Shomari; Amanda Leach; Erik Jongert; Nahya Salim; Jose F Fernandes; David Dosoo; Maria Chikawe; Saadou Issifou; Kingsley Osei-Kwakye; Marc Lievens; Maria Paricek; Tina Möller; Stephen Apanga; Grace Mwangoka; Marie-Claude Dubois; Tigani Madi; Evans Kwara; Rose Minja; Aurore B Hounkpatin; Owusu Boahen; Kingsley Kayan; George Adjei; Daniel Chandramohan; Terrell Carter; Preeti Vansadia; Marla Sillman; Barbara Savarese; Christian Loucq; Didier Lapierre; Brian Greenwood; Joe Cohen; Peter Kremsner; Seth Owusu-Agyei; Marcel Tanner; Bertrand Lell

• Book ID: 117791800
• Publisher: The Lancet
• Year: 2011
• Tongue: English
• Weight: 260 KB
• Volume: 11
• Category: Article
• ISSN: 1473-3099
• DOI: 10.1016/s1473-3099(11)70100-1